Abstract:
A rapidly deployable flexible enclosure system for the collection, containment and presentation of hydrocarbon emissions from compromised shallow or deepwater oil and gas well systems, pipelines, including subsea fissures.The flexible containment enclosure can accommodate any depth and adapt to any collection terminator configuration required.The flexible containment enclosure system is connected to the floating platform and supported by positive offset neutral buoyancy attachment devices.The floating platform may be assembled onshore and towed, ferried or assembled on site.Liquid and gaseous materials are directed to separate ports for removal from the rigid enclosure cavity integrated within the floating platform. Gaseous emissions may optionally be directed to a tethered floating flare system.The systems all weather capabilities include the ability to submerge for extended durations and resurface on demand by transmitted signal or manually providing operations during hurricanes, heaving seas, and other surface threats.
Abstract:
The present invention relates to a tag identification system comprising: a plurality of tags, each tag being identifiable by an associated tag identifier, and at least one tag comprising at least one link to at least one other tag in said group.
Abstract:
The present invention relates to the use of a compound or a mixture consisting of two or more compounds or containing one or more compounds selected from the group consisting of compounds of Formulae (I) and (ent-I) wherein in Formulae (I) and (ent-I) the following applies: the aromatic radical Ar is selected from the group consisting of: wherein in the aromatic radicals A and B the following applies: R1 and R2 are selected independently of one another from the group consisting of H, OH, OCH3, OCH2CH3, OCH(CH3)2, COOCH3, COOCH2CH3, COOCH(CH3)2, or R1 and R2 are adjacent and jointly form an OCH2O group, and wherein in the aromatic radical C the following applies: X is O or S as a flavoring substance or flavoring substance mixture.
Abstract:
For detecting a blocker RFID tag, the following steps are conducted. First, a random identifier of a given bit length is created. Alternatively, an identifier is selected out of a probing set, which is stored on a data storage device. The probing set comprises of identifiers, which are not being used as identifiers for a given set of RFID tags. In a second step, a response from all RFID tags is requested having an identifier matching the random identifier or, respectively, the selected identifier. In a third step, it is determined, depending on receiving or not receiving a response, whether the blocker RFID tag is present.
Abstract:
A rapidly deployable flexible enclosure system for the collection, containment and presentation of hydrocarbon emissions from compromised shallow or deepwater oil and gas well systems, pipelines, other structures, including subsea fissures. The flexible containment enclosure can accommodate various depths and collection terminator configurations. The flexible containment enclosure system is connected to a floating platform and supported by positive offset neutral buoyancy attachment devices. The floating platform with the flexible containment enclosure separates liquid and gaseous materials and directs them to separate ports for removal from a rigid enclosure cavity integrated within the floating platform. Gaseous emissions may optionally be directed to a tethered floating flare system. The system has the ability to partially or fully submerge for extended durations and resurface on demand manually or by transmitted signal. The system provides for operation by a combined tele-supervisory and autonomous control system.
Abstract:
The invention concerns the use of a deoxy hesperetin dihydrochalcone or a salt of the deoxy hesperetin dihydrochalcone (I) or a mixture comprising or consisting of a plurality of salts of the deoxy hesperetin dihydrochalcone (I) or a mixture comprising or consisting of deoxy hesperetin dihydrochalcone (I) and a salt or a plurality of salts of the deoxy hesperetin dihydrochalcone (I), to influence the strength of taste impressions of sweet-tasting, unpleasant-, in particular bitter-, tasting or both sweet- and unpleasant-, in particular bitter-, tasting substances or mixtures of substances.
Abstract:
The invention relates to the use of specific compounds from the structural class of vanillyl lignans or the salts and/or mixtures thereof for modifying or masking unpleasant taste impressions, in particular bitter, astringent, and/or metallic taste impressions. The invention also relates to a corresponding method for masking unpleasant taste impressions, in particular bitter, astringent, and/or metallic taste impressions. The invention further relates to specific preparations containing an effective amount of vanillyl lignans or the salts and/or mixtures thereof to be used in accordance with the invention.
Abstract:
The present invention primarily relates to the use of one or a plurality of neoflavonoids of formula (I) and/or one or a plurality of physiologically acceptable salts of one or a plurality of neoflavonoids of formula (I) for producing a sensory impression of sweetness (i.e. an impression of sweetness) in an orally consumable preparation or for intensifying the sensory impression of sweetness of an orally consumable preparation comprising at least one further sweet-tasting and/or sweet-smelling substance. The present invention further relates to certain semifinished products and certain orally consumable preparations containing one or a plurality of neoflavonoids of formula (I) and/or one or a plurality of physiologically acceptable salts of one or a plurality of neoflavonoids of formula (I). Finally the invention also relates to a method of producing an orally consumable preparation and a method of producing and/or intensifying a sensory impression of sweetness in/of an orally consumable preparation.
Abstract:
A description is given of precursor compounds of sweet taste receptor antagonists for the prevention or treatment of disease, in particular for the prevention or treatment of Type 2 diabetes.A description is also given of uses of these precursor compounds and edible compositions, preparations for nutrition or pleasure or semi-finished products and pharmaceutical preparations, containing such precursor compounds.